Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer at what cost?
暂无分享,去创建一个
[1] D. Appleton,et al. A protective effect of sulindac against chemically‐induced primary colonic tumours in mice , 1988, The Journal of pathology.
[2] P. Vielh,et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.
[3] C. Smart. Screening and early diagnosis , 1992, Cancer.
[4] O. Terpstra,et al. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. , 1987, Gastroenterology.
[5] L F Watson,et al. Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988. , 2007, International journal of epidemiology.
[6] C. Torrance,et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. , 1992, The New England journal of medicine.
[7] J. F. Fraumeni,et al. Incidence of cancer among patients with rheumatoid arthritis. , 1993, Journal of the National Cancer Institute.
[8] M. Langman,et al. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. , 1985, British medical journal.
[9] S. Shapiro,et al. Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. , 1988, Archives of internal medicine.
[10] S. Piantadosi,et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.
[11] J. Bordas,et al. Effects of long-term sulindac therapy on colonic polyposis. , 1991, Annals of internal medicine.
[12] J. Manson,et al. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. , 1993, Journal of the National Cancer Institute.
[13] T. Hanlon. Major upper gastrointestinal tract bleeding: Relation to the use of aspirin and other nonnarcotic analgesics , 1988 .
[14] T. Kudo,et al. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. , 1981, Cancer research.
[15] P. Greenwald. Colon cancer overview , 1992, Cancer.
[16] J. Kurata,et al. The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. , 1990, Journal of clinical gastroenterology.
[17] D. Ahlquist,et al. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. , 1992, Mayo Clinic proceedings.
[18] M. Odeh,et al. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease. , 1990, The American journal of gastroenterology.
[19] N. Petrelli,et al. Aspirin use, cancer, and polyps of the large bowel , 1993, Cancer.
[20] J. Baron,et al. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. , 1993, Journal of the National Cancer Institute.
[21] D. McCarthy,et al. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. , 1991, Annals of internal medicine.
[22] J. Baron,et al. Prospects for preventing colorectal cancer death. , 1993, Journal of the National Cancer Institute.
[23] H. A. Gardner,et al. Letter: Confirmation of antenatally detected trisomy-D from saline aborted products of conception. , 1974, Lancet.
[24] S. Skinner,et al. Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. , 1991, Archives of surgery.
[25] W. Waddell,et al. Sulindac for polyposis of the colon , 1983, Journal of surgical oncology.
[26] D M Clive,et al. Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.
[27] D. Graham,et al. Aspirin and the stomach. , 1986, Annals of internal medicine.
[28] B. Henderson,et al. Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.
[29] E. Cerise,et al. Sulindac for polyposis of the colon. , 1989, American journal of surgery.
[30] C. Hawkey,et al. Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin. , 1989, BMJ.
[31] S. Shankel,et al. Effects of Nonsteroidal Anti-Inflammatory Drugs on Prostaglandins and Renal Function , 1985 .
[32] S. Gabriel,et al. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. , 1991, Annals of internal medicine.
[33] J. G. Lewis,et al. Screening and Diagnosis , 1964 .
[34] G. Kelloff,et al. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. , 1987, Cancer research.
[35] M. Iida,et al. Treatment of desmoid tumors in Gardner's syndrome , 1988, Diseases of the colon and rectum.
[36] Morris Pollard,et al. Treatment of Chemically-Induced Intestinal Cancers with Indomethacin 1 , 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[37] F. DeRubertis,et al. Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. , 1992, Carcinogenesis.
[38] W. Ray,et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. , 1991, Annals of internal medicine.
[39] J. Buring,et al. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease. , 1991, The American journal of gastroenterology.
[40] D. Eddy,et al. Screening for colorectal cancer , 1992, The Lancet.
[41] J. Travers,et al. Aspirin use and reduced risk of fatal colon cancer. , 1992, The New England journal of medicine.
[42] K. Kinzler,et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.
[43] E. Whitacre,et al. Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. , 1992, Archives of internal medicine.
[44] Silvestre Carneiro,et al. SULINDAC TREATMENT FOR FAMILIAL POLYPOSIS COLI , 1985, The Lancet.
[45] S. Shapiro,et al. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. , 1991, Journal of the National Cancer Institute.
[46] Renal syndromes associated with non-steroidal anti-inflammatory drugs , 1984 .